Author: admin

The central laboratory of new hospitals performed more than 36 million of any analytical tests in 2 years.

|

central new hospital laboratory carries out more than 36 million Panel in 2 years.

Fernández-Lasquetty closed the second Conference on biomedical Diagnostics, organized on the occasion of the 2nd anniversary of this laboratory.


-samples of more than 4,500 patients are dealt with on a daily basis in this laboratory

– occupies an area of 2,500 square meters and offers service to over 1.2 million



Spain, June of 2011- the Health Minister in duties of the community of Madrid, Javier Fernández Lasquetty, has been closed on 13 June the II Jornadas de biomedical diagnosis in hospital Infanta Sofía, event organized on the occasion of the second anniversary of the Central Laboratory that since its opening in 2009 has received 2.452.040 requests for analysis and he has made a total of 36.338.986 evidence.

located in Hospital Infanta Sofía of San Sebastian de los Reyes (Madrid), the laboratory provides service to almost 1,200,000 inhabitants of the community of Madrid to give coverage to the Madrid public hospital Infanta Sofía, Infanta Cristina, Infanta Leonor, Southeast, Henares and Tagus, as well as to their respective areas of influence. In particular, through 11 different routes carry samples of more than 4,500 patients who are cared for on a daily basis, in more than 150 centres for health, clinics, nursing homes and other centres care.

in an area of 2,500 m2 distributed over three floors, are developed in an integrated manner, activities of clinical analysis, cynical biochemistry, hematology, immunology, genetics, microbiology and parasitology, as well as testing of blood and components compatibility blood.

at the global level, the laboratory has of a catalogue of 1,400 evidence of different disciplines in a high percentage have response within 24 hours. The center counts with the sample management system, robotic, with a chain of transport 22 linear metres, one of the largest in Europe, which docks 16 clinical of biochemical and immunochemical, in which evidence of more demand and complexity are processed media.

professionals that are members of its staff have been formed to provide a comprehensive service covering the needs of analytical tests above six hospitals and their areas of influence.



participation of Pedro l. Alonso, Mariano Barbacid and Valentín Fuster.

the day closed by Fernández-Lasquetty has counted with the participation of Dr. Peter l. Alonso, director of the Global Health Institute of Barcelona (CRESIB, Hospital Clínic-Universitat de Barcelona) who spoke on “ the challenges of global health, Dr. Valentine Fuster, director-general of the national centre of research cardiovascular Carlos III (CNIC) in Madrid and director of the Institute Cardiovascular of the Hospital Mount Sinai in New York that explained the “ Transition from Cardiovascular disease to health: 2010-2020 ” and finally, Dr. Mariano Barbacid, who gave a lecture titled: “ of the Molecular Oncology to individualized therapies ”.


Read More

Valencia hosted the most important meeting in Spain on hemodynamics & interventional cardiology.

|

Valencia hosted the most important meeting in Spain on hemodynamics and cardiology Interventional.

XXII annual section meeting of hemodynamics & interventional cardiology of the SEC.

-a length of Thursday and Friday Valencia hosted the 22ND annual meeting of the section of hemodynamics & interventional cardiology, Spanish society of Cardiology (SEC)

-the meeting was attended by more than 500 experts on hemodynamics and coronary intervention and was attended by important representatives in the field at the international level, as Professor Patrick w. Serruys

-the meeting was also attended by the President of the society Spanish of Cardiology (SEC), Dr. Carlos Macaya; of the President-elect of the SEC, Dr. Vicente Bertomeu, and the President of the section of hemodynamics & interventional cardiology of the SEC, Dr. Javier Goicolea

-implantation in Spain of the initiative Stent for Life, the analysis of the main cases of coronary intervention made during the last year or the current state of the cell therapy for cardiac regeneration are some of the main topics addressed

Valencia, 2011-June throughout Thursday and Friday, the section of hemodynamics & interventional cardiology, Spanish society of Cardiology (SEC) held their annual meeting, the more important that takes place in Spain on this subject.

The meeting, which took place in Santiago Grisolía Auditorium, located in the city of Arts and Sciences, Valencia, brought together more than 500 experts on hemodynamics and coronary intervention. Among the attendees they are important representatives at the international level, as it is the case of Professor Patrick w. Serruys, who gave the keynote: “ From Metallic Cage to Bioabsorbable Scaffold: A Change In Paradigm In The past Decade? ”.

In addition, other attendees include the Chairman of the SEC, Dr. Carlos Macaya; the President-elect of the SEC, Dr. Vicente Bertomeu, and the President of the section of hemodynamics & interventional cardiology of the SEC, Dr. Javier Goicolea.

Some of the main issues addressed are the evolution of the implementation of the initiative Stent for Life in Spain, which supports the primary angioplasty as best option for treatment after suffering a heart attack; the latest news on cell therapy for cardiac regeneration or the review of the most significant cases in coronary intervention.

On the occasion of the celebration of this annual meeting, it has also organized the meeting of the group work of nursing in hemodynamics and the meeting of the Working Group of senior technicians in medical image diagnostic.

Spanish society of Cardiology (SEC)

The Spanish society of Cardiology (SEC) is a scientific and professional organization non-profit dedicated to increasing the State of knowledge about the heart and the circulatory system, to make progress in the prevention and treatment of their diseases and to improve survival and quality of life for heart patients.

The SEC has among its principal objectives contribute to research international, especially Europe and Latin America, creating national and international links for the development of actions and represent all interested professionals in the field of cardiology.

Read More
Strawberries enhance red blood cells.

Strawberries enhance red blood cells.

|

Strawberries enhance blood cells red.

Spain, 2011-June A group of volunteers has taken half a kilo of strawberries a day average month to demonstrate that eat this fruit improves antioxidant capacity of blood. The analyses carried out by Italian and Spanish, researchers reveal that strawberries enhance red blood cells against oxidative stress, an imbalance related to various diseases.

So far scientists have attempted to confirm the antioxidant capacity of strawberries by in vitro experiments in the laboratory. Now, a team of researchers from the Universidad Politécnica de la Marche (UNIVPM, Italy) and of the University of Granada (UGR) has shown ‘ live ’ with people, as published in the journal Food Chemistry.

Scientists have provided 12 healthy volunteers 500 grams of strawberries (variety ‘ Swabian ’) throughout each day. Blood samples have been taken during 16 days: 4, 8, 12 and 16 days, and a month later. The results reveal that the regular consumption of this fruit can improve the antioxidant capacity of blood plasma and red blood cells to their hemolisis (fragmentation) resistance oxidative.

“ We have ascertained that some varieties of strawberries provide greater resistance of red blood cells against oxidative stress, which can be of great value if we consider that this phenomenon triggered serious pathologies ”, SINC highlights the principal author of the work, Maurizio Battino, UNIVPM.

strawberries are rich in antioxidants

team now analyzes variations when you swallow less amount of strawberries (usual consumption tends to be a cup a day with 150 or 200 g). “ important thing is that they are part of a healthy and balanced diet, in the five daily servings of fruits and vegetables ”, points Battino.

Looking for the most antioxidant variety

“ In the laboratory also being analysed different varieties of strawberries, as each one has its own amounts and proportions of antioxidants ”, explains José Luis Quiles, the Spanish participant in the study and researcher at the UGR.

The Agency has a broad array of antioxidant mechanisms that act at various levels and diverse nature. Cellular tools that repair material can be genetic when it is oxidized, or manufactured by our agency or ingested through diet molecules that neutralize free radicals. Strawberries have large amount of phenolic compounds such as flavonoids, exercising as these antioxidants.

These substances decrease oxidative stress, an imbalance that occurs in some situations (such as vascular, cancer or diabetes disease) pathological and physiological (birth, aging, physical exercise) between aggression that produce “ reactive species in the oxygen ” – radicals, in particular – and the body’s antioxidant defenses.

When the oxidation antioxidant defense produces oxidative stress, which, in addition to being the origin of certain diseases, also is involved in such phenomena as the speed which we age, for example.

–
Bibliographic references:

Sara Tulipani, José M. Álvarez-Suarez, Franco Busco, Stefano Bompadre, José l. Quiles, Bruno Mezzetti, Maurizio Battino. “ Strawberry consumption improves plasma antioxidant status and erythrocyte resistance to oxidative haemolysis in humans ”. Food Chemistry 128 (1): 180-186, September 2011 (available online from March 9, 2011). DOI:10.1016/j.foodchem.2011.03.025.

Read More

A new treatment get cured for 7 of every 10 patients of hepatitis C and reduce the duration of the therapy.

|

a new treatment manages to cure 7 of every 10 patients of hepatitis C and reduce the duration of the therapy.

– telaprevir, inhibitor of the protease, has proved effective when combined with routine treatment for hepatitis C, making up 70% of healings.

– the duration of the treatment could be reduced from 1 year to 6 months in patients who demonstrate a positive in the first 4 weeks.

Spain, 2011-July Hepatólogos of the Hospital del Mar and the IMIM Institut of research of the Hospital of the sea, they have participated in the study Advance, the results of which have been published this week in The New England Journal of Medicine. The study evaluates the results of a clinical trial in phase III of a new drug for the treatment of hepatitis C, the Telaprevir.This drug, when combined with the classical treatment Pegylated and Ribavirin, interferon has shown to improve its effectiveness in patients with genotype 1, the subgroup more frequent, since 70 per cent of those affected by hepatitis C in Europe have this genotype and at the same time the most difficult to cure. The drug has already received approval from the FDA (Food and Drug Administration) in United States and shortly, will receive the European and national consent.This new drug will also involve the reduction of the time of treatment, from 1 year to 6 months in patients who receive a positive response in the first 4 weeks.

a new treatment for hepatitis C.

the study Advance of multi-faceted character, which has included a total of 1088 patients who had previously received no treatment, was designed to evaluate the effectiveness of telaprevir (protease inhibitor), and at the same time, to help establish best patterns administration.

the telepravir associated with the treatment of hepatitis C known up to now, the pegylated interferon and Ribavirin, confirmed positive results in relation to virological response in patients with hepatitis C with genotype 1, who had not received previous treatment and allowed only to obtain response with 24 weeks of treatment. “ hepatitis C genotype 1 is the most common and is also the most difficult to cure. Thanks to the new drugs can increase the effectiveness of treatment and, in some cases, reduce its duration. If before there was a 40-45% response rate, we are now moving between 69 and 75% ”, explains Dr. Ricard Solà, Chief of the section of hepatology of the Hospital of the sea, researcher at the IMIM and one of the authors of this article.

the study has confirmed an optimal response of viral suppression and low rates of relapse after stopping the treatment. In this sense, these results point to the possibility of reducing the time of treatment from one year to 24 weeks in patients who have a rapid response. “ An improvement in terms of virological response sustained, i.e., the number of patients that eliminated the virus during treatment and until 6 months after it has been confirmed. When you get this milestone can be said that the patient is cured and therefore stops the disease progression to cirrhosis or liver cancer ”, explains Dr. Solà. “ new drug for hepatitis C, telaprevir i boceprevir, increase the effectiveness of the treatment but have a high economic cost and determine more side effects. For this reason, in Catalonia, are working to establish appropriate and common criteria in order to rationalize their use in daily clinical practice ”.

epidemiology of hepatitis C.

hepatitis C is an infection caused by a virus that is detected in the blood of the people who the suffering. in the European Union, the prevalence of hepatitis C lies between 2 and 3% of the population. The acute virus C infection is often asymptomatic and may cronificar in 50-70% of cases. Chronic hepatitis C patients have a higher risk of cirrhosis and liver cancer. Treatments that had been made during the last decade with interferon Pegylated and Ribavirin had given a 40-50% cure rate in patients with genotipo1.

Read More

The community hopes 34,500 blood donations in the summer campaign which starts on Monday.

|

The community expected 34,500 blood donations in the summer campaign which begins Monday.

the Chief presided over the Act of recognition of hospitals and their professionals for their participation in the marathons of blood.

-There will be more than 600 mobile points of donation throughout the campaign

– this summer will be established donation points in the facilities of the Madrid Institute for sport

– so far this year the number of donations has increased by 4%

Madrid, 2011-July Health Minister Javier Fernández-Lasquetty presided at the center of transfusion the Act of recognition of Madrid hospitals and their professional counseling for his involvement in the marathons of blood donation that has been among his staff.

Fernández-Lasquetty recalled in the Act on Monday starts the donation campaign of summer, which aims to get 34,500 donations and that among the new features of the campaign is the establishment of fixed points of donation in the network of facilities of the Madrid Institute of sport.

In the face of the summer blood needs not lower, given that patients still need treatment and, at the same time, the Centre for transfusion must have larger reserves than at other times of the year, since there is a lesser availability of donors before needs urgent and random.

summer of blood donation campaign reach, through mobile units for donation, 156 municipalities of the community, which represents more than 600 mobile points to the length of the campaign as well as 26 daily fixed points (24 public hospitals)(, Mobile unit in the Puerta del Sol and transfusion centre). Monday through Friday be carried out 11 daily collections, five on Saturday and two on Sunday, with a unit in the Retiro Park.

This year they will also install fixed points of donation in three facilities of the IMDER (instituto Madrileño sport) in the Parque Deportivo Puerta de Hierro, in the Canal de Isabel II and the St. Vincent de Paul. The aim is to convert these facilities on a point of reference for their environment and link the habits of healthy living, as the practice of physical activity, the habit of donating blood; In addition, donors who come to these points them presented with a free a day ticket for the IMDER-dependent pools.

From January 1 through June 21 this year were obtained in the community of Madrid 91.811 blood donations, an increase of 4% on donations obtained in the same period of the previous year. Blood donation allowed by the year 2010 for 284.626 transfusion of blood components, essential for a multitude of medical and surgical treatments.

The transfusion Center offers information on blood donation here . To donate blood no special requirements; any person 18 years of age or older and less than 65 years, with normal health and with a weight that exceeds the 50 kilos can do so in any of the points of donation, fixed or mobile, the community of Madrid.

award-winning campaign

initiatives Trasfusión Centre carried out to collect blood include blood donation marathons that are made between health professionals and hospitals public.

This initiative has earned the distinction to the “ national merit 2011 ” by the Spanish Federation of blood donors. The work done with this campaign has been awarded also the prize “ silver drop ” by the Spanish society of blood transfusion and Cellular therapy.

Recognition of the hospitals in Madrid

In addition, the community wanted today publicly acknowledge the work done by professionals in Madrid hospitals collaborating with a campaign of advocacy and awareness with the motto “ you can also ”, launched in October 2009. Since then and until now, have been 72 blood donation marathons among staff of 27 hospitals, which have achieved a total of almost 7,000 donations.

The ceremony presided by Fernández-Lasquetty took delivery of a diploma of participation in the campaign all hospitals and two special awards, to Hospital Gregorio Marañón being which brought the more donations and Hospital Santa Cristina being that has a higher percentage of donations by number of professionals in template.

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips